Do Traders Think Veru Inc (VERU) Can Turn Around Thursday?

Veru Inc (VERU) stock is lower by 2.04% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Veru Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VERU!

See Full VERU Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With VERU Stock Today?

Veru Inc (VERU) stock has gained 4.92% while the S&P 500 is down -0.2% as of 1:37 PM on Thursday, Nov 30. VERU is up $0.04 from the previous closing price of $0.92 on volume of 463,988 shares. Over the past year the S&P 500 is up 14.76% while VERU is down -82.61%. VERU lost -$1.52 per share in the over the last 12 months.

More About Veru Inc

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. Click Here to get the full Stock Report for Veru Inc stock.